Michael G. Leitner
University of Marburg
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael G. Leitner.
The Journal of Physiology | 2011
Moritz Lindner; Michael G. Leitner; Christian R. Halaszovich; Gerald R.V. Hammond; Dominik Oliver
Non‐technical summary The electrical activity of nerve cells is produced by the flux of ions through specialized membrane proteins called ion channels. Some ion channels can be regulated by the signalling lipid PIP2, a component of the channels’ membrane environment. Here we examine the relevance of PIP2 for the regulation of one specific channel type, termed TASK. Many chemical transmitters in the brain change neural activity by shutting off TASK channels and it has been suggested that this results from reduction of PIP2. By using novel techniques to alter the concentration of PIP2 in living cells, we find that the activity of TASK is independent of PIP2. Besides demonstrating that another signalling mechanism must control the activity of nerve cells via TASK inhibition, we delineate a general approach for clarifying the relevance of PIP2 in many cell types and organs.
Nature Communications | 2014
Bettina U. Wilke; Moritz Lindner; Lea Greifenberg; Alexandra Albus; Yannick Kronimus; Moritz Bünemann; Michael G. Leitner; Dominik Oliver
The two-pore domain potassium (K2P) channels TASK-1 (KCNK3) and TASK-3 (KCNK9) are important determinants of background K(+) conductance and membrane potential. TASK-1/3 activity is regulated by hormones and transmitters that act through G protein-coupled receptors (GPCR) signalling via G proteins of the Gαq/11 subclass. How the receptors inhibit channel activity has remained unclear. Here, we show that TASK-1 and -3 channels are gated by diacylglycerol (DAG). Receptor-initiated inhibition of TASK required the activity of phospholipase C, but neither depletion of the PLC substrate PI(4,5)P2 nor release of the downstream messengers IP3 and Ca(2+). Attenuation of cellular DAG transients by DAG kinase or lipase suppressed receptor-dependent inhibition, showing that the increase in cellular DAG-but not in downstream lipid metabolites-mediates channel inhibition. The findings identify DAG as the signal regulating TASK channels downstream of GPCRs and define a novel role for DAG that directly links cellular DAG dynamics to excitability.
Journal of Biological Chemistry | 2011
Jérôme J. Lacroix; Christian R. Halaszovich; Daniela N. Schreiber; Michael G. Leitner; Francisco Bezanilla; Dominik Oliver; Carlos A. Villalba-Galea
The recently discovered voltage-sensitive phosphatases (VSPs) hydrolyze phosphoinositides upon depolarization of the membrane potential, thus representing a novel principle for the transduction of electrical activity into biochemical signals. Here, we demonstrate the possibility to confer voltage sensitivity to cytosolic enzymes. By fusing the tumor suppressor PTEN to the voltage sensor of the prototypic VSP from Ciona intestinalis, Ci-VSP, we generated chimeric proteins that are voltage-sensitive and display PTEN-like enzymatic activity in a strictly depolarization-dependent manner in vivo. Functional coupling of the exogenous enzymatic activity to the voltage sensor is mediated by a phospholipid-binding motif at the interface between voltage sensor and catalytic domains. Our findings reveal that the main domains of VSPs and related phosphoinositide phosphatases are intrinsically modular and define structural requirements for coupling of enzymatic activity to a voltage sensor domain. A key feature of this prototype of novel engineered voltage-sensitive enzymes, termed Ci-VSPTEN, is the novel ability to switch enzymatic activity of PTEN rapidly and reversibly. We demonstrate that experimental control of Ci-VSPTEN can be obtained either by electrophysiological techniques or more general techniques, using potassium-induced depolarization of intact cells. Thus, Ci-VSPTEN provides a novel approach for studying the complex mechanism of activation, cellular control, and pharmacology of this important tumor suppressor. Moreover, by inducing temporally precise perturbation of phosphoinositide concentrations, Ci-VSPTEN will be useful for probing the role and specificity of these messengers in many cellular processes and to analyze the timing of phosphoinositide signaling.
Molecular Pharmacology | 2011
Michael G. Leitner; Christian R. Halaszovich; Dominik Oliver
Aminoglycoside antibiotics (AGs) are severely ototoxic. AGs cause degeneration of outer hair cells (OHCs), leading to profound and irreversible hearing loss. The underlying mechanisms are not fully understood. OHC survival critically depends on a specific K+ conductance (IK,n) mediated by KCNQ4 (Kv7.4) channels. Dysfunction or genetic ablation of KCNQ4 results in OHC degeneration and deafness in mouse and humans. As a common hallmark of all KCNQ isoforms, channel activity requires phosphatidylinositol(4,5)bisphosphate [PI(4,5)P2]. Because AGs are known to reduce PI(4,5)P2 availability by sequestration, inhibition of KCNQ4 may be involved in the action of AGs on OHCs. Using whole-cell patch-clamp recordings from rat OHCs, we found that intracellularly applied AGs inhibit IK,n. The inhibition results from PI(4,5)P2 depletion indicated by fluorescence imaging of cellular PI(4,5)P2 and the dependence of inhibition on PI(4,5)P2 availability and on PI(4,5)P2 affinity of recombinant KCNQ channels. Likewise, extracellularly applied AGs inhibited IK,n and caused substantial depolarization of OHCs, after rapid accumulation in OHCs via a hair cell-specific apical entry pathway. The potency for PI(4,5)P2 sequestration, strength of IK,n inhibition, and resulting depolarization correlated with the known ototoxic potential of the different AGs. Thus, the inhibition of IK,n via PI(4,5)P2 depletion and the resulting depolarization may contribute to AG-induced OHC degeneration. The KCNQ channel openers retigabine and zinc pyrithione rescued KCNQ4/IK,n activity from AG-induced inhibition. Pharmacological enhancement of KCNQ4 may thus offer a protective strategy against AG-induced ototoxicity and possibly other ototoxic insults.
The Journal of General Physiology | 2015
Balázs István Tóth; Maik Konrad; Debapriya Ghosh; Florian Mohr; Christian R. Halaszovich; Michael G. Leitner; Joris Vriens; Johannes Oberwinkler; Thomas Voets
TRPM3 is dynamically regulated by plasma membrane PI(4,5)P2 and related PIPs.
Frontiers in Pharmacology | 2015
Alexandra Rjasanow; Michael G. Leitner; Veronika Thallmair; Christian R. Halaszovich; Dominik Oliver
The activity of many proteins depends on the phosphoinositide (PI) content of the membrane. E.g., dynamic changes of the concentration of PI(4,5)P2 are cellular signals that regulate ion channels. The susceptibility of a channel to such dynamics depends on its affinity for PI(4,5)P2. Yet, measuring affinities for endogenous PIs has not been possible directly, but has relied largely on the response to soluble analogs, which may not quantitatively reflect binding to native lipids. Voltage-sensitive phosphatases (VSPs) turn over PI(4,5)P2 to PI(4)P when activated by depolarization. In combination with voltage-clamp electrophysiology VSPs are useful tools for rapid and reversible depletion of PI(4,5)P2. Because cellular PI(4,5)P2 is resynthesized rapidly, steady state PI(4,5)P2 changes with the degree of VSP activation and thus depends on membrane potential. Here we show that titration of endogenous PI(4,5)P2 with Ci-VSP allows for the quantification of relative PI(4,5)P2 affinities of ion channels. The sensitivity of inward rectifier and voltage-gated K+ channels to Ci-VSP allowed for comparison of PI(4,5)P2 affinities within and across channel subfamilies and detected changes of affinity in mutant channels. The results also reveal that VSPs are useful only for PI effectors with high binding specificity among PI isoforms, because PI(4,5)P2 depletion occurs at constant overall PI level. Thus, Kir6.2, a channel activated by PI(4,5)P2 and PI(4)P was insensitive to VSP. Surprisingly, despite comparable PI(4,5)P2 affinity as determined by Ci-VSP, the Kv7 and Kir channel families strongly differed in their sensitivity to receptor-mediated depletion of PI(4,5)P2. While Kv7 members were highly sensitive to activation of PLC by Gq-coupled receptors, Kir channels were insensitive even when PI(4,5)P2 affinity was lowered by mutation. We hypothesize that different channels may be associated with distinct pools of PI(4,5)P2 that differ in their accessibility to PLC and VSPs.
British Journal of Pharmacology | 2016
Michael G. Leitner; Niklas Michel; Marc Behrendt; Marlen Dierich; Sandeep Dembla; Bettina U. Wilke; Maik Konrad; Moritz Lindner; Johannes Oberwinkler; Dominik Oliver
Signalling through phospholipase C (PLC) controls many cellular processes. Much information on the relevance of this important pathway has been derived from pharmacological inhibition of the enzymatic activity of PLC. We found that the most frequently employed PLC inhibitor, U73122, activates endogenous ionic currents in widely used cell lines. Given the extensive use of U73122 in research, we set out to identify these U73122‐sensitive ion channels.
Journal of Lipid Research | 2012
Christian R. Halaszovich; Michael G. Leitner; Angeliki Mavrantoni; Audrey Le; Ludivine Frezza; Anja Feuer; Daniela N. Schreiber; Carlos A. Villalba-Galea; Dominik Oliver
In voltage-sensitive phosphatases (VSPs), a transmembrane voltage sensor domain (VSD) controls an intracellular phosphoinositide phosphatase domain, thereby enabling immediate initiation of intracellular signals by membrane depolarization. The existence of such a mechanism in mammals has remained elusive, despite the presence of VSP-homologous proteins in mammalian cells, in particular in sperm precursor cells. Here we demonstrate activation of a human VSP (hVSP1/TPIP) by an intramolecular switch. By engineering a chimeric hVSP1 with enhanced plasma membrane targeting containing the VSD of a prototypic invertebrate VSP, we show that hVSP1 is a phosphoinositide-5-phosphatase whose predominant substrate is PI(4,5)P2. In the chimera, enzymatic activity is controlled by membrane potential via hVSP1’s endogenous phosphoinositide binding motif. These findings suggest that the endogenous VSD of hVSP1 is a control module that initiates signaling through the phosphatase domain and indicate a role for VSP-mediated phosphoinositide signaling in mammals.
British Journal of Pharmacology | 2012
Michael G. Leitner; Anja Feuer; Olga Ebers; Daniela N. Schreiber; Christian R. Halaszovich; Dominik Oliver
BACKGROUND AND PURPOSE DFNA2 is a frequent hereditary hearing disorder caused by loss‐of‐function mutations in the voltage‐gated potassium channel KCNQ4 (Kv7.4). KCNQ4 mediates the predominant K+ conductance, IK,n, of auditory outer hair cells (OHCs), and loss of KCNQ4 function leads to degeneration of OHCs resulting in progressive hearing loss. Here we explore the possible recovery of channel activity of mutant KCNQ4 induced by synthetic KCNQ channel openers.
Frontiers in Pharmacology | 2015
Angeliki Mavrantoni; Veronika Thallmair; Michael G. Leitner; Daniela N. Schreiber; Dominik Oliver; Christian R. Halaszovich
Voltage sensitive phosphatases (VSPs), including engineered voltage sensitive PTEN, are excellent tools to rapidly and reversibly alter the phosphoinositide (PI) content of the plasma membrane in vivo and study the tumor suppressor PTEN. However, widespread adoption of these tools is hampered by the requirement for electrophysiological instrumentation to control the activity of VSPs. Additionally, monitoring and quantifying the PI changes in living cells requires sophisticated microscopy equipment and image analysis. Here we present methods that bypass these obstacles. First, we explore technically simple means for activation of VSPs via extracellularly applied agents or light. Secondly, we characterize methods to monitor PI(4,5)P2 and PI(3,4,5)P3 levels using fluorescence microscopy or photometry in conjunction with translocation or FRET based PI probes, respectively. We then demonstrate the application of these techniques by characterizing the effect of known PTEN mutations on its enzymatic activity, analyzing the effect of PTEN inhibitors, and detecting in real time rapid inhibition of protein kinase B following depletion of PI(3,4,5)P3. Thus, we established an approach that does not only allow for rapidly manipulating and monitoring PI(4,5)P2 and PI(3,4,5)P3 levels in a population of cells, but also facilitates the study of PTEN mutants and pharmacological targeting in mammalian cells.